International consensus statement for the use of botulinum toxintreatment in adults and children with neurological impairments – introduction: Esquenazi A et al.

Introduction: People with neurological conditions such as stroke,cerebral palsy, cervical dystonia, Parkinson’s disease, Motor Neurone Disease, Multiple Sclerosis and brain injury experience many impairments, including sensorimotor disorders, that limit their activities, participation and quality of life. …

European Journal of Neurology 2010, 17 (Suppl. 2): 1–8

doi:10.1111/j.1468-1331.2010.03125.x

Autoren:
A. Esquenazi a,

I. Novak b,

G. Sheean c,

B. J. Singer d

and A. B. Ward e

Autoren-Details:

a Moss Rehab Gait & Motion Analysis Laboratory, Department of PM&R, Elkins Park, PA, USA;

b Cerebral Palsy Institute, School of Medicine, University of Notre Dame Australia, Darlinghurst, Sydney, New South Wales, Australia;

c Neurosciences, University of California, San Diego, California, USA;

d Centre for Musculoskeletal Studies, School of Surgery, The University of Western Australia, Perth, Australia;

and e North Staffordshire Rehabilitation Centre, University Hospital of North Staffordshire (Haywood Hospital), Stoke on Trent, UK

Bitte hier klicken!